Description:
The Journal of Nanotoxicology and Nanomedicine (JNN) publishes key research that addresses the potential opportunities, hazards, and risks associated with human and environmental exposure to micro-scale materials in natural as well as medicinal settings. Focusing on both theoretical and... Show More
The Journal of Nanotoxicology and Nanomedicine (JNN) publishes key research that addresses the potential opportunities, hazards, and risks associated with human and environmental exposure to micro-scale materials in natural as well as medicinal settings. Focusing on both theoretical and experimental research in molecular nanotechnology, nanotoxicolocy, and nanomedicine, this journal is an ideal reference source for medical and pharmaceutical professionals, chemists, engineers, environmental scientists, academics, and upper-level students.
Mission & Scope:
The mission of the Journal of Nanotoxicology and Nanomedicine (JNN) is to promote positive human health, including environmental well-being, better diagnosis and treatments of medical conditions, and improving the natural biological structure and function of humans through new knowledge discovery in the field of micro-scale medicine and toxicology. JNN aims to advance the available research in... Show More
The mission of the Journal of Nanotoxicology and Nanomedicine (JNN) is to promote positive human health, including environmental well-being, better diagnosis and treatments of medical conditions, and improving the natural biological structure and function of humans through new knowledge discovery in the field of micro-scale medicine and toxicology. JNN aims to advance the available research in this field and also enable future research developments.
Coverage:
- Biodistribution of nanomaterials
- Biorenewable materials
- Chemonanoinformatics
- Colloidal and particulate materials
- Environmental Applications
- Functional materials
- Multicore nanotechnology
- Nanobiomaterials
- Nanobioscience
- Nanobiotechnology
- Nanodescriptors development
- Nanodiagnostic devices
- Nanoinformatics
- Nanomaterials in gene therapy
- Nanomaterials in medical imaging technologies
- Nanomedical devices
- Nanomedicine
- Nanoparticle characterization
- Nano-QSAR
- Nanoscale devices
- Nanosensors
- Nanotechnology
- Nanotherapeutics
- Pharmacokinetics of nanomaterials
- Polymeric Materials
- Safety assessment
- Toxicology of nanomaterials
IGI Global holds its journals to the highest ethical practices.
View Full Editorial PolicyAs this journal is under the Hybrid Open Access model, authors can choose between Standard (Non-OA) publishing or Open Access publishing. Find the policies for the publishing models below:
- Standard (Non-OA) Publishing: If the author chooses to publish under the Standard (Non-OA) model, the article will be published under a Green OA model and the copyright of
their article will transfer to IGI Global under our Author Warranty and Transfer of Copyright Agreement.
However, through Green OA, IGI Global supports a Fair Use Policy, enabling authors to Post the final
typeset PDF (which includes the title page, table of contents and other front materials, and the copyright
statement) of their chapter or article (NOT THE ENTIRE BOOK OR JOURNAL ISSUE), on the author or
editor's secure personal website and/or their university repository site. See the Fair Use Policy for sharing allowances conducive to Green Open Access.
- Open Access Publishing: If the author choses to publish under OA, the authors receive the
Creative Commons Attribution 4.0 International (CC BY 4.0) licensing arrangement. The copyright for the
work remains solely with the author(s) of the article. Others may distribute, remix, tweak, and build upon
the work, even commercially, without asking prior permission from the publisher or author and so long as
they credit the author for the original creation. All authors are required to sign an author's warranty
stating that the materials are original and unpublished elsewhere. The journal will not publish any
material that has been previously published elsewhere. Learn More
This journal operates under the Hybrid Open Access model,
allowing the author to choose between traditional, subscription-based publishing, or Open Access publishing.
Subscription-Based Publishing/Green Open Access:
Article manuscripts require no Article Processing Charge (APC) and require authors to transfer the copyright of the
manuscript to IGI Global. Manuscripts are published behind a paywall and must be purchased for use. See the
Fair Use Policy
for sharing allowances conducive to Green Open Access.
Open Access Publishing:
Article manuscripts receive the Creative Commons Attribution 4.0 International
(CC BY 4.0) licensing arrangement. The copyright for the work remains solely with the author(s) of
the article. Others may distribute, remix, tweak, and build upon the work, even commercially, without asking
prior permission from the publisher or author and so long as they credit the author for the original creation.
A one-time Article Processing Charge (APC) of US $2,300 must be paid AFTER the manuscript has gone
through the full double-blind peer review process and the Editor(s)-in-Chief at his/her/their full discretion
has decided to accept the manuscript based on the results of the double-blind peer review process. Learn
more about APCs
here.
Open Access Funding:
IGI Global recognizes that many researchers may not know where to begin when searching for OA funding opportunities. IGI Global recently
launched an
Open Access Funding Resources
page for researchers to browse. This page provides a comprehensive list of OA funding sources available for researchers to secure funds
for their various OA publications.
Author Services Inquiries
For inquiries involving pre-submission concerns, please contact the Journal Development Division:
journaleditor@igi-global.comOpen Access Inquiries
For inquiries involving publishing costs, APCs, etc., please contact the Open Access Division:
openaccessadmin@igi-global.comProduction-Related Inquiries
For inquiries involving accepted manuscripts currently in production or post-production, please contact the Journal Production Division:
journalproofing@igi-global.comRights and Permissions Inquiries
For inquiries involving permissions, rights, and reuse, please contact the Intellectual Property & Contracts Division:
contracts@igi-global.comPublication-Related Inquiries
For inquiries involving journal publishing, please contact the Acquisitions Division:
acquisition@igi-global.comDiscoverability Inquiries
For inquiries involving sharing, promoting, and indexing of manuscripts, please contact the Citation Metrics & Indexing Division:
indexing@igi-global.com Editorial Office
701 E. Chocolate Ave.
Hershey, PA 17033, USA
717-533-8845 x100
The Journal of Nanotoxicology and Nanomedicine (JNN) is owned and published by IGI Global.
Journal of Nanotoxicology and Nanomedicine (JNN) is editorially independent, with full authority of the journal's content falling to the Editor-in-Chief and the journal's
Editorial Board.
The In-House Editorial Office manages the publishing operations of the journal.
IGI Global
701 East Chocolate Avenue
Hershey, PA 17033
USA
Principal Contact
Grace Long
Managing Editor of Journal Development
IGI Global
Phone: (717) 533-8845 ext. 147
E-mail: glong@igi-global.com
Support Contact
Donna Wilkie
Development Editor - Journal of Nanotoxicology and Nanomedicine (JNN)
IGI Global
Phone: 717-533-8845
E-mail: